Skip to main content

Closed

UPB: Upstream Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+20.4% / yr

Operating margin-5176.5%

ROIC-56.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio23.14×

Upstream Bio, Inc.

UPBNASDAQ Global Select·USD·Closed

Upstream Bio, Inc.

UPBNASDAQ·USD·Closed

$6.31

−3.96%

$6.31

−$0.26 (3.96%)

52W Range

2thpctl

Volume

0.47×avg

Mkt Cap

343.39MUSD

P/E

-2.2TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.47×avg

Market Cap

343.39MUSD

P/E Ratio

-2.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings